SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UnitedHealth Group Incorporated

NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980 The investigation concerns whether UnitedHealth and certain of its officers and/or directors have involvement in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On February 27, 2024, The Wall Street Journal (“WSJ”) reported that the US Department of Justice (“DOJ”) has launched an antitrust investigation into UnitedHealth. Specifically, the WSJ reported…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc.

NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Alignment and certain of its officers and/or directors have involved in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On or around March 29, 2021Alignment conducted its initial public offering (“IPO”), selling 27.2 million shares of common stock priced at $18.00 per share. Then, on February 27,…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp.

NEW YORK, March 19, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Anavex and certain of its officers and/or directors have involvement in securities fraud or other unlawful business practices. You have until May 13, 2024to ask the Court to…